Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 High incidence rate of genetic disorders
3.2.1.2 Technological advancements
3.2.1.3 Growing demand for early and non-invasive diagnosis
3.2.1.4 Shift toward non-invasive testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Ethical considerations and cost of the test
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Epidemiology scenario
3.11 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables & reagents
5.3 Instruments
5.4 Services
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 NGS
6.3 PCR
6.4 cfDNA
6.5 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Trisomy detection
7.3 Microdeletion detection
7.4 Sex chromosome aneuploidy detection
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 BGI
10.3 Centogene N.V.
10.4 Eurofins LifeCodexx GmbH
10.5 F. Hoffmann-La Roche Ltd.
10.6 IGENOMIX
10.7 Illumina, Inc.
10.8 Labcorp
10.9 MedGenome Labs Ltd.
10.10 Myriad Women’s Health, Inc.
10.11 Natera, Inc.
10.12 Pacific Biosciences
10.13 PerkinElmer Inc.
10.14 Progenity, Inc.
10.15 Quest Diagnostics, Inc
